I.BelcherR
Mechanism of Action Dual GLP-1 receptor and GIP receptor co-agonism
Patients should disclose a history of pancreatitis, gallbladder disease, severe gastrointestinal disease, kidney disease or dehydration risk, use of diabetes medications such as insulin or sulfonylureas, pregnancy or plans for pregnancy, and any personal or family history of medullary thyroid carcinoma or MEN2
How soon should I expect to see results with microdosing
If a dose is missed, the missed dose should be skipped , and the next dose should be taken the following day
Lets review how Wegovy 7.2 mg compares to the highest weekly dose of Mounjaro, based on data from a 72-week tirzepatide trial: If youre interested in the new higher Wegovy dose, you may still have some questions about why it was introduced or whether it will be available on the NHS